For example, comparing intracranial glioma CSF to lumbar NPH samples might suggest that fibroblast growth factor-1 (FGF1) is elevated in gliomas (Figure 3A) (C. Riviere-Cazaux, T. Burns, personal communication, November 5, 2024). This evidence concerns the gene FGF1 and central nervous system cancer.